Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Egypt / NCT05947331
Active, not recruiting Not applicable

Correction of Head Turn in Idiopathic Infantile Nystagmus

NCT05947331 · tracked via the Priya Life Science Egypt tracker
Sponsor
Zagazig University
Phase
Not applicable
Started
2022-04-05
Last updated
2025-01-24

Condition(s) studied

Infantile Nystagmus Syndrome

Investigational drug(s) / intervention(s)

Graded Anderson procedureKestenbaum procedure

Graded Anderson procedure: In graded Anderson proceduren only recession of yoke muscles is done.

Kestenbaum procedure: In Kestenbaum procedure, recession of yoke muscles and resection of their antagonists is done based on Parks table for Kestenbaum procedure according to the preoperative amount of head turn.

Study summary

Infantile nystagmus is involuntary, bilateral, conjugate and rhythmic oscillations of the eyes which may present at birth or develop within the first 6 months of life. It may be idiopathic appearing without visual or neurological impairment or may be secondary to an afferent visual defect such as foveal hypoplasia, congenital cataract, retinal dystrophy or optic atrophy. Aiming at improving outcome of head turn in idiopathic infantile nystagmus, comparison between the efficacy and safety of graded Anderson procedure and Kestenbaum procedure is essential.

Eligibility

Sex
ALL
Min age
5 Years
Max age
30 Years
Healthy volunteers
No
Inclusion Criteria: Orthophoric Patients with idiopathic infantile nystagmus related head turn (≥20 degrees - ≤ 45 degrees) that is verified at least twice in two separate visits. Exclusion Criteria: 1. Patients with infantile nystagmus secondary to ocular diseases 2. Patients with infantile nystagmus with associated strabismus. 3. Previous squint, scleral buckling or glaucoma surgeries. 4. Associated systemic or neurological disorders. 5. Patients with anisometropia ≥ 5D. 6. Patients with nystagmus attenuated at near

Primary outcome measure(s)

  • Degree of head turn — Base line and 6 months postoperatively.
    assess the change from Baseline degree of head turn at 6 months postoperatively using protractor goniometer

Trial sites (1)

FacilityCityRegionStatus
Zagazig University Zagazig Zagazig

More Zagazig University trials in Egypt

Combined Microneedling With Either 1% Lactic Acid Solution or Vitamin D3 or Triamcinolone Acetonide in The Treatment of Alopecia Areata Recruiting
Total Intravenous Anesthesia in Patients Undergoing Craniotomy Active, not recruiting
Outcomes of Using FANS With FURS in TTT of Lower Calyceal Stones. Recruiting
Clinical Performance of Laryseal Clear Versus Ambu Aura 40 Laryngeal Mask Airway for Preschool Children Recruiting
Management Modalities of Chronic Pelvic Pain Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05947331 on ClinicalTrials.gov ↗ ← All trials in Egypt